| NBM | normal bone marrow |
| FceRII | Fc-epsilon receptor II |
| IL-2RA | interleukin-2 receptor alpha chain |
| DPPIV | dipeptidyl peptidase IV |
| IAP | integrin associated protein |
| NCAM | neural cell adhesion molecule |
| G-CSFR | granulocyte colony-stimulating factor receptor |
| PROM1 | prominin-1 |
| PD-L1 | programmed cell death-ligand 1 |
| CLL-1 | C-type lectin-like molecule-1 |
| IL-1RAP | interleukin-1 receptor accessory protein |
| n.c. | not yet clustered |
| LSC | leukemic stem cells |
| AML | acute myeloid leukemia |
| CT | chemotherapy |
| HSCT | hematopoietic stem cell transplantation |
| AML | acute myeloid leukemia |
| NCT | national clinical trial identifier |
| BiTE | bispecific T cell engagers |
| TriKE | tri-specific killer engager |
| DART | dual affinity retargeting antibody |
| CAR | chimeric antigen receptor |
| NK | natural killer cell |
| AML | acute myeloid leukemia |
| MDS | myelodysplastic syndrome |
| R/R | refractory/resistant |
| USA | United States of America |
| HSCT | hematopoietic stem cell transplantation |
| DCN | dendritic cell neoplasm |
| NK | killer cells |
| RAEB | refractory anemia with excess of blasts |
| NKG2D | natural killer group 2D antigen |